Bimekizumab Clinical Efficacy in Important Body Regions and Health-related Quality of Life in Patients with Plaque Psoriasis: Data from Four Phase 3/3b Comparator-controlled Trial Periods

Main Article Content

April Armstrong
Boni Elewski
Phoebe Rich
Matthias Augustin
José-Manuel Carrascosa
Ronald Vender
Jérémy Lambert
José M. López Pinto
Bengt Hoepken
Sarah Kavanagh
Luis Puig

Keywords

psoriasis, bimekizumab, quality of life, scalp, nail, palmoplantar, high-impact areas, clinical trial, efficacy

Abstract

 


 

References

1. Timotijević ZS et al. Acta Dermatovenerol Croat 2017;25:215–22

2. Strober B et al. J Dermatolog Treat 2024;35:2287401

3. Augustin M & Radtke MA. Expert Rev Pharmacoecon Outcomes Res 2014;14:559–68

4. Reich K et al. Lancet 2021;397:487–98, NCT03370133

5. Gordon KB et al. Lancet 2021;397:475–86, NCT03410992

6. Warren RB et al. N Engl J Med 2021;385:130–41, NCT03412747

7. Reich K et al. N Engl J Med 2021;385:142–52, NCT03536884

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>